Infection with hepatitis C virus (HCV) is usually established by detec
tion of serum antibodies (anti-HCV). This study was conducted in order
to evaluate whether saliva and urine may substitute serum for anti-HC
V detection. Serum, saliva, and urine were obtained simultaneously fro
m 141 patients with a variety of liver diseases and from 52 patients w
ith autoimmune diseases; (systemic lupus erythematosus n = 27 and rheu
matoid arthritis n = 25). The cell free fraction of saliva and urine s
amples was tested for anti-HCV using a modification of a serum anti-HC
V kit. Western blot analysis was used as a confirmation method. Of the
patients with liver diseases, 73 were anti-HCV-seropositive. Salivary
and urinary anti-HCV could be detected in 66 (90%) and 36 (49%) of th
e anti-HCV-serpositive patients, respectively. The presence of anti-HC
V in saliva or urine was not related to the severity of liver disease.
All the anti-HCV-seronegative liver patients were negative for saliva
ry anti-HCV and 22 (32%) had urinary anti-HCV. The patients with autoi
mmune diseases were all anti-HCV-seronegative. None had detectable sal
ivary anti-HCV while 33 (63%) were positive for urinary anti-HCV. West
ern Blot analysis confirmed the presence of anti-HCV in all serum and
saliva samples tested but only in 2/12 urine samples. The results sugg
est that saliva, but not urine, may serve as a substitute for serum fo
r the determination of anti-HCV positivity. (C) 1998 Wiley-Liss, Inc.